CNIO has taken the top spot from the Cancer Institute of the Netherlands (NKI), which had been ranked first for several years
Worldwide, CNIO is ranked in fourth place by Nature Index, only surpassed by the three main cancer research centres in the US
"We are very proud when we see that, in spite of the difficulties we have in our country to develop high-level science, CNIO is still ranked as one of the best institutions in the world," explains Maria A. Blasco, the Centre’s Director
The prestigious international Nature Index ranks the Spanish National Cancer Research Centre (CNIO) top among all the cancer research centres in Europe, in the area of health and life sciences. CNIO has taken this top spot from the Cancer Institute of the Netherlands (NKI), which had been leading this ranking in recent years. In addition, CNIO is the only Spanish research centre among the top 30 positions.
In terms of its position at a global level, CNIO is the fourth highest-ranking cancer research centre in the area of health and life sciences. It is only surpassed by the three leading centres in the US: MD Anderson (Houston), the Memorial Sloan-Kettering Cancer Center (New York) and the Dana Farber Institute (Boston). In this world ranking, CNIO is again the only Spanish institution in the top 100.
Nature Index compares the scientific production of more than 9,000 research centres around the world published in leading scientific journals. This Index is the most important ranking in terms of assessing the contribution made by each centre to the progress of science within their respective areas of expertise, and it takes into account the quality of scientific production and collaboration established at an institutional, national and local level.
The level (impact) of scientific journals is evaluated by measuring the number of citations received by the articles published (which indicates the relevance of the research conducted in the pertinent area of expertise). The more relevant the researches published in a journal, the greater its impact factor (IF). To name just a few, CNIO publishes in the most important journals in the area of cancer research, such as Cancer Cell (IF 22.8) or The Journal of Clinical Oncology (IF 26), as well as general medical research, such as The New England Journal of Medicine (IF 79), and any area of research, such as Nature (41.5).
In this respect, CNIO has been generating more and more high quality scientific production in recent years, and indeed 2018 was the third year in which the Centre published an increasing number of studies in peer-reviewed journals with an IF greater than 10 – led by the Centre or in collaboration with other institutions.
“One of our priorities is to continue producing knowledge of excellence in the area of cancer”, explains Maria A. Blasco, director of CNIO. “We are very proud when we see that, in spite of the difficulties we have in our country to develop high-level science, CNIO is still ranked alongside the best institutions in the world. Our efforts are rewarded with esteemed recognition such as the Nature Index”.